Skip to main content
Home
FULL MENU Close Menu
Home
Home

Jennifer Smith

Jennifer Smith is the editor of Oncology Practice, part of MDedge Hematology/Oncology. She was previously the editor of Hematology Times, an editor at Principal Investigators Association, and a reporter at The Oneida Daily Dispatch. She has a BS in journalism.

News

FDA approves fedratinib for myelofibrosis

Author:
Jennifer Smith
Publish date: August 16, 2019

Fedratinib is approved to treat adults with intermediate-2 or high-risk primary or secondary myelofibrosis.

  • Read More

News

Review reveals lack of data on mild hemophilia A

Author:
Jennifer Smith
Publish date: August 13, 2019

A review of 17 studies showed limited and inconsistent data on bleeding, joint pain, quality of life, and other outcomes.

  • Read More

Article

Cancer centers announce new faculty

Author:
Jennifer Smith
Publish date: August 12, 2019

New appointments at Georgia Cancer Center, Fox Chase, and the Oncology Institute of Hope and Innovation.

  • Read More

News

Transient opioid use linked to COPD exacerbation

Author:
Jennifer Smith
Publish date: August 8, 2019

Opioid exposure in the prior 7 days was associated with an 80.8% increase in the odds of exacerbation.

  • Read More

News

Timing, volume of transfusion may not matter in children with severe anemia

Author:
Jennifer Smith
Publish date: July 31, 2019

The TRACT trial showed no significant differences in 28-day mortality or other clinical outcomes by transfusion timing or volume.

  • Read More

Article

ASTRO announces new president-elect, board members

Author:
Jennifer Smith
Publish date: July 29, 2019

The new ASTRO president-elect plans to address physician burnout, restrictive prior authorization practices, and diversity in the workforce.

  • Read More

News

U.S. fertility rate, teen births are on the decline

Author:
Jennifer Smith
Publish date: July 26, 2019

The report from the Centers for Disease Control and Prevention also found an increase in vaginal births after previous cesarean delivery.

  • Read More

News

Results support first-line T-DM1 in HER2+ breast cancer

Author:
Jennifer Smith
Publish date: July 25, 2019

A phase 3 trial showed similar overall survival times in patients who received trastuzumab emtansine (T-DM1), T-DM1 plus pertuzumab, or...

  • Read More

News

BTK mutations linked to CLL progression on ibrutinib

Author:
Jennifer Smith
Publish date: July 24, 2019

The findings support mutational analysis in CLL patients on ibrutinib, according to researchers.

  • Read More

News

CAR T-cell therapy less effective in transformed follicular lymphoma

Author:
Jennifer Smith
Publish date: July 22, 2019

The complete response rate and duration of response were better in patients with follicular lymphoma than in those with transformed follicular...

  • Read More

News

Guidelines update donor selection criteria for HSCT

Author:
Jennifer Smith
Publish date: July 19, 2019

The evidence-based guidelines provide recommendations for selecting adult donors and cord blood units for allogeneic hematopoietic stem cell...

  • Read More

News

Large genetic cohort supports NfL as Alzheimer’s biomarker

Author:
Jennifer Smith

LOS ANGELES – Mutation carriers in the world’s largest early onset AD cohort saw significant increases in neurofilament light (NfL) from age 22...

  • Read More

News

Test could inform care of patients with pancreatic cysts

Author:
Jennifer Smith
Publish date: July 17, 2019

The test, CompCyst, correctly identified 91% of patients who required surgery, 49% of those who required monitoring, and 60% of patients who...

  • Read More

News

Investigators target brain metastases in NSCLC

Author:
Jennifer Smith
Publish date: July 16, 2019

In a retrospective study of matched primary and metastases samples, PI3K signaling was associated with an increased risk of brain metastases, and...

  • Read More

Article

Endoscopic treatment effective in T1b esophageal cancer

Author:
Jennifer Smith
Publish date: July 15, 2019

A systematic review suggests endoscopic treatment is appropriate for T1b esophageal cancers with a low risk of metastasis.

  • Read More

Pages

  • « first
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close